Condition: Gastrointestinal Stromal Tumors · Unresectable Solid Tumor · Recurrent Metastatic Malignant Neoplasm · Sponsor: Xinhua Zhang, MD
This is a prospective, multicenter, observational real-world study to explore the therapy patterns and clinical outcomes of Avapritinib in patients with metastatic or unresectable gastrointestinal stromal tumors.
This description comes directly from the study's public registry record.
Xinhua Zhang, PhD · +8620-87332200 · zhangxinhua@mail.sysu.edu.cn
Always discuss trial participation with your own doctor first.
| The First Affiliated Hospital, Sun Yat-sen University | Guangzhou, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05464875